Orotic Acid

Orotic Acid

SCHEMBL175081

O=C(O)c1cc(=O)[nH]c(=O)[nH]1.c1ccc2c(c1)CCNCC2

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.62
LMNA P02545 2/20 0.62
HTR2C P28335 2/20 0.47
TSHR P16473 1/20 0.44
CYP2C19 P33261 2/20 0.42
GPR84 Q9NQS5 1/20 0.42
KDM4E B2RXH2 4/20 0.42
HSD17B10 Q99714 3/20 0.42
CYP1A2 P05177 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HPGD P15428 2/20 0.42
GRIN2D O15399 1/20 0.42
GRIN3B O60391 1/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
MAPK1 P28482 1/20 0.42
AHR P35869 1/20 0.42
CHRNA7 P36544 1/20 0.42
GRIN1 Q05586 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Orotic Acid SCHEMBL163210 0.83 ALDH1A1 (0.58) ALDH1A1LMNATSHRCYP2C19GPR84
Orotic Acid SCHEMBL174876 0.83 HTR2C (0.59) ALDH1A1LMNAHTR2CTSHRHTR2B
Orotic Acid SCHEMBL162920 0.83 ALDH1A1 (0.45) ALDH1A1LMNAHTR2CTSHRGPR84
Orotic Acid SCHEMBL165966 0.82 ALDH1A1 (0.50) ALDH1A1LMNAHTR2CTSHRCYP2C19
Orotic Acid SCHEMBL5651941 0.80 ALDH1A1 (0.95) ALDH1A1LMNATSHRCYP2C19GPR84
Orotic Acid SCHEMBL672212 0.80 ALDH1A1 (0.72) ALDH1A1LMNATSHRCYP2C19GPR84
Orotic Acid SCHEMBL162921 0.79 ALDH1A1 (0.53) ALDH1A1LMNATSHRCYP2C19GPR84
Orotic Acid SCHEMBL29394966 0.79 ALDH1A1 (1.00) ALDH1A1LMNATSHRCYP2C19GPR84
Orotic Acid SCHEMBL431534 0.79 ALDH1A1 (1.00) ALDH1A1LMNATSHRCYP2C19GPR84
Orotic Acid SCHEMBL20865 0.79 ALDH1A1 (1.00) ALDH1A1LMNATSHRCYP2C19GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012030953-A1 5-HT2C RECEPTOR AGONISTS IN THE TREATMENT OF DISORDERS AMELIORATED BY REDUCTION OF NOREPINEPHRINE LEVEL ARENA PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed